Publications by authors named "Marc Renaud"

Claim this Profile
P
Pulmonary toxoplasmosis in immunocompromised patients with interstitial pneumonia: a single-centre prospective study assessing PCR-based diagnosis.
Guillaume Desoubeaux, Églantine Cabanne, Claire Franck-Martel, Martin Gombert, Emmanuel Gyan, Marc Renaud

J Clin Pathol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.
Hélène Labussière Wallet, Mohamad Sobh, Stéphane Morisset, Marie Robin, Nathalie Fegueux, Marc Renaud

Exp Hematol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Celso A Rodrigues, Guillermo Sanz, Claudio G Brunstein, Jaime Sanz, John E Wagner, Marc Renaud

J Clin Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Mauricette Michallet, Quoc-Hung Le, Mohamad Mohty, Thomas Prébet, Franck Nicolini, Marc Renaud

Exp Hematol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial.
Thierry Facon, Jean Yves Mary, Cyrille Hulin, Lotfi Benboubker, Michel Attal, Marc Renaud

Lancet· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
Stéphane Vigouroux, Mauricette Michallet, Raphaël Porcher, Michel Attal, Lionel Ades, Marc Renaud

Haematologica· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.
Hervé Avet-Loiseau, Michel Attal, Philippe Moreau, Catherine Charbonnel, Frédéric Garban, Marc Renaud

Blood· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.
Michel Attal, Jean-Luc Harousseau, Serge Leyvraz, Chantal Doyen, Cyrille Hulin, Marc Renaud

Blood· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.
Jean-Luc Harousseau, Michel Attal, Xavier Leleu, Jacques Troncy, Brigitte Pegourie, Marc Renaud

Haematologica· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, Michel Attal, Marc Renaud

Blood· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang study.
Eric Deconinck, Mathilde Hunault, Noël Milpied, Marc Bernard, Marc Renaud

Biol Blood Marrow Transplant· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).
Marie Cividin, Françoise Brizard, Nathalie Sorel, Marc Renaud, François Guilhot

Leuk Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis